Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017021983) PARTICULATE DELIVERY SYSTEMS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/021983 International Application No.: PCT/IN2016/050261
Publication Date: 09.02.2017 International Filing Date: 05.08.2016
IPC:
A61K 31/00 (2006.01) ,A61K 31/736 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
736
Glucomannans or galactomannans, e.g locust bean gum, guar gum
Applicants:
RUBICON RESEARCH PRIVATE LIMITED [IN/IN]; Rubicon Research Private Limited 221, Annexe Building, Goregaon Mulund Link Road Off. L.B.S Marg, Bhandup West Mumbai 400078, IN
Inventors:
PILGAONKAR, Pratibha; IN
GANDHI, Anilkumar; IN
JAIN, Paras; IN
Priority Data:
2969/MUM/201506.08.2015IN
Title (EN) PARTICULATE DELIVERY SYSTEMS
(FR) SYSTÈMES D'ADMINISTRATION PARTICULAIRES
Abstract:
(EN) The present invention provides particulate delivery systems comprising plurality of particles comprising fenugreek gum and at least one pharmaceutically acceptable excipient. The particulate delivery systems of the present invention are used for the delivery of therapeutic, immunologic or diagnostic agents, and the like.
(FR) La présente invention concerne des systèmes d'administration particulaires comprenant une pluralité de particules comprenant de la gomme de fenugrec et au moins un excipient pharmaceutiquement acceptable. Les systèmes d'administration particulaires de la présente invention sont utilisés pour l'administration d'agents thérapeutiques, immunologiques ou diagnostiques, et similaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)